Stephen Cornelissen/LinkedIn
Feb 4, 2026, 08:05
Stephen Cornelissen Honors the Life-Saving Impact of Blood Donation on World Cancer Day
Stephen Cornelissen, CEO of Australian Red Cross Lifeblood, shared on LinkedIn:
”On World Cancer Day, I’m reminded that behind every diagnosis is a person and a story shaped by resilience, fear, hope, and the people who stand beside them.
Blood cancer patients are the largest users of donated blood in Australia.
More than a third of all whole blood donations support cancer treatment, helping patients stay strong enough to undergo chemotherapy and other intensive therapies.
These donations don’t treat the cancer itself, but they make treatment possible.
It highlights the vital role Australian Red Cross Lifeblood donors play in supporting patients through treatment.”
Stay updated with Hemostasis Today.
-
Mar 16, 2026, 16:14Siobhan Calafiore: Clinical Advantages of Apixaban Over Rivaroxaban in Reducing Bleeding Risk
-
Mar 16, 2026, 16:12Nuha El Sayed: Focused Summary of the 2026 ACC/AHA Guideline on Management of Dyslipidemia in Diabetes
-
Mar 16, 2026, 16:08Deepak Sudheendra: When a Vascular Looking Skin Pattern Isn’t Vascular
-
Mar 16, 2026, 16:06Surendra Karki։ Examining Blood Type and Coronary Heart Disease Risk in Australian Donors
-
Mar 16, 2026, 15:58Alan Nurden: Genome-Wide Analyses Unravel the Genetic Architecture of Coagulation and Fibrinolysis
-
Mar 16, 2026, 15:56Emmanuel J. Favaloro: Latest Publication from Sydney Centres on Heparin Therapy and Monitoring
-
Mar 16, 2026, 15:53Suvro Sankha Datta: Reporting Auto-Anti-Jk Antibodies in Children with Hematological Disorders
-
Mar 16, 2026, 15:44Francis Kynaston-Pearson: Why Randomised Controlled Trials Are the Gold Standard in Clinical Research
-
Mar 16, 2026, 15:18Kalpana Gupta Shekhawat: A Practical Clinical Approach to Iron Regulation